Dexter, MI, United States of America

Emily M Jutkiewicz


Average Co-Inventor Count = 6.5

ph-index = 1


Company Filing History:


Years Active: 2015-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Emily M. Jutkiewicz and Her Groundbreaking Work on Nicotinic Receptor Compounds

Introduction: Emily M. Jutkiewicz is an accomplished inventor based in Ann Arbor, Michigan, renowned for her innovative contributions to the field of pharmacology, particularly in the development of compounds aimed at promoting smoking cessation and reducing nicotine addiction. With one patent to her name, her work showcases the intersection of science and public health.

Latest Patents: Emily's patent focuses on nicotinic receptor compounds, specifically designed to aid in smoking cessation or decrease tobacco use. The patent describes compounds and compositions that utilize 2'-fluoro-3′-(substituted phenyl) deschloroepibatidine analogs. These compounds modulate neuronal nicotine acetylcholine receptors, making them valuable in treating conditions that are influenced by the modulation of these receptors. This innovation not only represents a significant step forward in addiction treatment but also highlights Jutkiewicz's contribution to improving public health.

Career Highlights: Over her career, Emily has demonstrated a strong commitment to research and innovation. She has worked with notable institutions such as the Research Triangle Institute and the University of Michigan. Her tenure at these organizations has provided her with a solid foundation to conduct groundbreaking research that addresses critical issues related to nicotine addiction.

Collaborations: Throughout her career, Emily has collaborated with distinguished scientists, including Frank Ivy Carroll and Pauline Wanjiku Ondachi. These partnerships have undoubtedly enriched her research and facilitated the advancement of her innovative work in nicotinic receptors.

Conclusion: Emily M. Jutkiewicz exemplifies the spirit of innovation in the field of pharmacology. Her patented nicotinic receptor compounds not only reflect her dedication to solving pressing societal challenges related to nicotine addiction but also underscore her significant contributions to scientific advancement. As she continues her work, Emily remains a pivotal figure in the ongoing efforts to promote health and well-being through innovative research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…